Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
22.30%
↑ 433% above average
Average (14q)
-6.70%
Historical baseline
Range
High:29.45%
Low:-52.83%
Volatility
-1227.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 22.30% |
| Q2 2025 | 20.07% |
| Q1 2025 | -25.97% |
| Q4 2024 | 12.09% |
| Q3 2024 | -38.85% |
| Q2 2024 | 2.05% |
| Q1 2024 | -52.83% |
| Q4 2023 | 29.45% |
| Q3 2023 | -49.60% |
| Q2 2023 | 27.96% |
| Q1 2023 | -27.99% |
| Q4 2022 | 14.53% |
| Q3 2022 | -12.63% |
| Q2 2022 | -21.13% |
| Q1 2022 | 0.00% |